← All trials
NCT04621916
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 21, 2020
- Primary completion
- Sep 21, 2022
- Completion date
- Sep 21, 2022
- First posted
- Nov 9, 2020
- Last posted
- Nov 9, 2020
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Children's Hospital Los AngelesLead sponsor
- Children's Hospital Los AngelesReponsible party - principal investigator
- GrifolsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.